NC PCI Progress Report, February 2012
Impact of HSV-2 suppressive therapy with daily acyclovir on HIV-1 disease progression: a randomized placebo- controlled trial in Rakai, Uganda Steven J.
Steven J. Reynolds, MD, MPH National Institute of Allergy and Infectious Diseases
Abstract Authors
NC PCI Progress Report, Februry 2012
